Supports Nucleofection® of various cell numbers in 100 µL cuvettes or 20 µL 16-well strips
The medium-throughput module for the 4D-Nucleofector® Platform suited for transfection of hard-to-transfect cell lines or primary cells in 96-well format
Enables the direct Nucleofection® of cells in adherence in 24-well culture plates
The controlling unit of the 4D-Nucleofector® System is suited to handle various functional units for efficient transfection of hard-to-transfect cell lines and primary cells in different formats.
Next generation large-scale Nucleofector® Platform for closed, scalable transfection of up to 1 billion cells – from research to GMP manufacturing
Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Test to determine if β-D-glucans are present in a sample.
-
4D-Nucleofector® Protocol for PANC-1Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for PANC-1
-
PANC-1 Transfection Protocol - 4D-Nucleofector™ X-UnitInstructions of use for transfection of PANC-1 cells with the SE Cell Line 4D-Nucleofector™ X Kit
-
PANC-1 Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of PANC-1 cells with the Cell Line Nucleofector™ Kit R
-
Lonza Bioscience Clinical Technologies – Your Trusted Partner in Regenerative Medicine
-
The Importance of Cell-subtype Selection in Creation of a 3D Liver Fibrosis ModelData sheet detailing 3D liver fibrosis model in collaboration with Visikol
-
Instructions - QCL-1000™ Assay (English)Detailed instructions for performing the QCL-1000™ Endpoint Chromogenic LAL Assay
-
Metabolism_Brochure_CoBrand_FormThis is a co-marketing form for distributors. There is a restricted space on the cover next to the Lonza logo and on the back below the market bar. Art for placement MUST be a PDF. In addition there is space on the back cover for a web address at the top and contact and disclaimers. Please look for the instruction PDF in the literature DB Article number CD-FO006Inst
-
2018 Endotoxin Testing Summit Report: Entering a New Era for Endotoxin TestingWhite Paper Report provides an update on current trends from the key stakeholders in the endotixin testing community, gives details on the key topics discussed, and looks at what the future holds for endotoxin testing.
-
Lonza - Closer Than You Think - Corporate Brochure
-
Cell Therapy Services - Your Product. Our Passion.